Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use [Carta]: a case report (2010)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- Subjects: NEOPLASIAS INTESTINAIS (PATOLOGIA); DOENÇAS DO COLON (PATOLOGIA); DIAGNÓSTICO DIFERENCIAL; SEGUIMENTOS
- Language: Inglês
- Imprenta:
- Source:
-
ABNT
FERNANDES, Gustavo dos Santos et al. Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use [Carta]: a case report. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.scielo.br/pdf/clin/v65n6/13.pdf. Acesso em: 12 mar. 2026. , 2010 -
APA
Fernandes, G. dos S., Katz, A., Calabrich, A., & Hoff, P. M. (2010). Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use [Carta]: a case report. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.scielo.br/pdf/clin/v65n6/13.pdf -
NLM
Fernandes G dos S, Katz A, Calabrich A, Hoff PM. Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use [Carta]: a case report [Internet]. Clinics. 2010 ; 65( 6): 645-646.[citado 2026 mar. 12 ] Available from: http://www.scielo.br/pdf/clin/v65n6/13.pdf -
Vancouver
Fernandes G dos S, Katz A, Calabrich A, Hoff PM. Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use [Carta]: a case report [Internet]. Clinics. 2010 ; 65( 6): 645-646.[citado 2026 mar. 12 ] Available from: http://www.scielo.br/pdf/clin/v65n6/13.pdf - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
